Skip to main content
. Author manuscript; available in PMC: 2015 Mar 6.
Published in final edited form as: Exp Clin Psychopharmacol. 2010 Feb;18(1):78–86. doi: 10.1037/a0018060

Table 1.

Demographic characteristics of participants in each treatment group

0mg (N=16) 50mg (N=14) 100mg (N=14)
Agea 21.8±0.9 21.2±0.7 22.6±0.8

Body Mass Indexa (kg/m2) 22.0±0.6 23.6±0.6 23.6±0.4

Full time Student (#) 11 12 8

Education (%)
 High school 13 7 14
 Partial college 56 93 57
 College degree 31 0 29

Caffeine consumptiona (cups/week) 3.9±1.0 5.0±1.6 6.0±2.2

Alcohol consumptiona (drinks/week) 4.7±1.0 5.3±0.9 4.9±1.7

Race (%)
 White 63 79 64
 Black 12 0 14
 Asian 6 14 8
 Other 19 7 14

Drug Use (% ever used)
 Cannabis 69 50 64
 Stimulants 25 0 7
 Opiates 31 7 21
 Tranquilizers 0 0 0
 Hallucinogens 19 7 14
a

Data is presented as mean±SEM.